Eye disease drugs
These companies develop drugs and gene therapies for eye diseases such as dry eye and retinal disease.
+42.0%
over 1 year · S&P 500 +11.6%
Key indicators
Health
47 / 100
Fragile
Solid
Price
P/E 17
Cheap
Expensive
Up over 1 year
17 of 27
Volatility
71%
Calm
Choppy
Health and price: against the other tags.
Key indicators
When a figure has a bar, the marker places it among its peers, and the further right it sits, the more the figure beats the others. Green marks the best third, red the weakest and white anything in between. Some figures stay white wherever they sit, like price, pace or holding time, because neither side is better there.
The 28 companies
REGN
+40.9%
GKOS
+165.3%
KOD
Others
Size: weight in the tag. Color: move over the period.
See all companies
See all companies
R
Regeneron Pharmaceuticals
REGN
66.6%
+40.9%
G
Glaukos
GKOS
10.2%
+165.3%
K
Kodiak Sciences
KOD
4.9%
+449.1%
B
Belite Bio
BLTE
4.4%
+48.3%
V
Viridian Therapeutics
VRDN
2.4%
+6.7%
T
Tarsus Pharmaceuticals
TARS
2.4%
+7.3%
S
Stoke Therapeutics
STOK
1.2%
+6.2%
A
ANI Pharmaceuticals
ANIP
1.2%
−18.1%
O
Ocular Therapeutix
OCUL
1.0%
−46.0%
S
SpyGlass Pharma
SGP
0.8%
H
Harrow
HROW
0.8%
−21.6%
M
MeiraGTx Holdings
MGTX
0.7%
+6.0%
A
Aura Biosciences
AURA
0.6%
+27.6%
A
Annexon
ANNX
0.6%
+38.0%
F
4D Molecular Therapeutics
FDMT
0.5%
+11.5%
D
Design Therapeutics
DSGN
0.5%
+37.6%
S
Surrozen
SRZN
0.4%
+144.3%
R
REGENXBIO
RGNX
0.4%
−34.1%
I
Opus Genetics
IRD
0.3%
+107.3%
Y
Yarrow Bioscience
YARW
0.1%
+86.4%
L
LENZ Therapeutics
LENZ
<0.1%
−83.8%
A
Aldeyra Therapeutics
ALDX
<0.1%
−87.9%
E
EyePoint
EYPT
<0.1%
−97.4%
A
ABVC BioPharma
ABVC
<0.1%
−69.6%
A
Alcon
ALC
−6.4%
B
Bausch Health Companies
BHC
+20.3%
B
Bausch + Lomb
BLCO
+27.0%
O
Oculis Holding
OCS
−59.6%